Adrian Adams Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Adrian Adams is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 200,500 shares of AKBA, which is worth approximately $771,925. The most recent transaction as insider was on Jun 10, 2025, when has been sold 35,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 201K
21.66% 3M change
21.66% 12M change
Total Value Held $771,925

ADRIAN ADAMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Grant, award, or other acquisition
-
35,700 Added 15.11%
200,500 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 15.4%
164,800 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 18.2%
134,800 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
13,700 Added 11.56%
104,800 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
13,700 Added 13.07%
91,100 Common Stock

Also insider at

ACRX
ACELRX PHARMACEUTICALS INC Healthcare
IMPL
IMPEL PHARMACEUTICALS INC Healthcare
COB, CEO and President
AA

Adrian Adams

Hayward, CA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA